Inclusion Criteria:
- Age range between 30 to 50 years.
- Male and female patients will participate in the study.
- All patients have chronic rhinosinusitis, who are experiencing 12 weeks or longer of 2 or more of the following signs and symptoms:
mucopurulent drainage (anterior, posterior, or both) nasal obstruction (congestion) facial pain-pressure-fullness, or decreased sense of smell
• All patients enrolled in the study will have their informed consent.
Exclusion Criteria:
- Patients with metal implants (pacemakers, dental implants, or any other implants).
- Patients with cancer, pregnancy or impaired vascular circulation.
- Patients who suffer from mental or psychological disorders.
- Patients with any systemic diseases that may interfere with the objectives of the study.
- Patients with long-term use of corticosteroids or immunosuppressive agents.
- Congenital defects on face and nose.
- Fracture of nose or face.
- Patients who are contraindicated for corticosteroids use in patient who will receive dexamethasone phonophoresis.
- Allergic patients.
- Pervious nasal surgery.
- Patients with nasal septum deviation.
- patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks or any medication that may interfere with the objectives of the study.